AL.CHI.MI.A. S.R.L. is a leading European manufacturer of medical devices. Currently, we carry two product lines: Ophthalmic Surgery and Human Tissue Processing (HTP). Products for Ophthalmic Surgery include intraoperative and long-term endotamponades for vitreoretinal surgery, dyes to visualize tissues to be extirpated during cataract and vitreoretinal surgical procedures, and an ophthalmic gel to be used to protect the corneal surface during ophthalmic surgeries, and in ophthalmology. The HTP line offers products to process human tissues and cells intended for transplantation, and includes decontamination, storage, and transport solutions, and a device for antibiotic removal, before performing the sterility tests.
Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning more than seven decades, we offer the broadest portfolio of products to enhance sight and improve people’s lives. Our Surgical and Vision Care products touch the lives of more than 260 million people in over 140 countries each year living with conditions like cataracts, glaucoma, retinal diseases and refractive errors. Our more than 20,000 associates are enhancing the quality of life through innovative products, partnerships with eye care professionals and programs that advance access to quality eye care. Learn more at www.alcon.com.
Alfa Intes, a family business with more than six decades of experience in the pharmaceutical industry, is an italian leading ophthalmological holding. Its board portfolio consists of drugs, medical device, nutraceuticals surgical equipment and high-tech diagnostic instruments, marketed under different subsidiaries, all engaged to the same goal: Becoming the main landmark for the entire eye-care community
Alimera Sciences Limited is a pharmaceutical company that specialises in the commercialisation and development of prescription ophthalmic pharmaceuticals. It was founded in 2003 and is currently focused on diseases affecting the posterior segment of the eye. For more information, please visit www.alimerasciences.eu
As a leader in eye care, Allergan has discovered, developed, and delivered some of the most innovative products in the industry for more than 70 years. Allergan has launched over 125 eye care products and invested billions of dollars in new treatments for the most prevalent eye conditions including glaucoma, ocular surface disease, and retinal diseases such as diabetic macular edema and retinal vein occlusion. Our eye care pipeline includes over a dozen additional agents for multiple ocular conditions. We remain steadfast in helping eye care providers deliver the best in patient care through innovative products and outreach programs.
Altris AI builds ophthalmology diagnosis real-time support platform for the automatic, structural and quantitative analysis and detection of glaucoma, age-related macular degeneration, diabetic retinopathy and other retinal diseases on Optical Coherence Tomography scans.
The company has accumulated and legally owns massive anonymized databases of the retina, optic nerve scans, and images as well as clinical data
Altris AI’s algorithms have been trained using OCT scans collected for 12 years and are able to detect more than 100 pathological signs, retinal diseases and conditions. The model shows the high level of performance with multi-disease classification accuracy more than 96%.
Aprofol AG, a Swiss Start-up, focused on applications of reduced Folate for the treatment and prevention of chronic diseases. Based on findings of US-ophthalmologists with the supplementation of bioactive folate in eye diseases such as age-related macular degeneration (AMD) and diabetic retinopathy (DR), Aprofol AG has launched Ocufolin®, a complete eye-vitamin formulation proved to reduce efficiently elevated levels of Homocysteine, a known and widely accepted risk factor in AMD and DR. To address multiple pathways as identified in sound studies like BMES, WAFACS and CAREDS, Ocufolin® includes, additionally to the AREDS formulation, L-Methylfolate, vitamin D and synergistic ingredients.
Safety first is Arcad objective when designing ,manufacturing and commercializing fluids dedicated to retinal detachment surgeries.
Arcaline, arcotane; retinal cells tests for each perfluorocarbon batches released ,give the highest guarantee of notoxicity.
Arciolane : a fractionation process of the siliconoil to reduce D2 /D9 polymers and postop emulsification.
Monoblue : a 97% trypanblue purification for a safe staining + Mannitol for an improved tolerance.
Arceole: a single-use set of pressurized gas for a reliable mixing.
Opcover : a corneal protection during surgery, for a post op comfort of the patient.
With over 166 years of innovation, Bausch+Lomb is a leading global eye care brand with expertise in contact lenses and lens care, pharmaceuticals and eye surgery. Our Surgical Division provides a complete product portfolio for Cataract, Refractive, Corneal and Retinal surgery.] new[With over 166 years of innovation, Bausch+Lomb is a leading global eye care brand with expertise in contact lenses and lens care, pharmaceuticals and surgery. The Surgical Division provides a complete product portfolio for cataract, refractive, corneal and retinal surgery. This includes our combined Stellaris Elite™ system, designed to deliver optimized control and efficiency to a wide range for cataract and retinal procedures, the BiBlade® vitrectomy cutter with its dual port design and our Vitesse® hypersonic vitrectomy system for a new approach to vitreous removal. Combined with our comprehensive instrument range, we provide for individual surgeon techniques and patient needs.
Bayer in ophthalmology aims to reduce the number of people impacted by visual impairment through innovation. Bayer is committed to addressing unmet needs, including identifying ways to minimize the treatment burden, increase treatment effectiveness and discover new eye therapies. Bayer offers a recognized treatment for various retinal diseases, such as neovascular (wet) age-related macular degeneration, diabetic macular edema and retinal vein occlusion. PP-EYL-ALL-0664-1
CANON MEDICAL SYSTEMS
Canon Medical offers a full range of diagnostic medical imaging solutions including CT, X-Ray, Ultrasound and MRI, across the globe. As of December 2016, Canon Medical became a member of the Canon Group. In line with our continued Made For life philosophy, patients are at the heart of everything we do. Our mission is to provide medical professionals with solutions that support their efforts in contributing to the health and wellbeing of patients worldwide. Our goal is to deliver optimum health opportunities for patients through uncompromised performance, comfort and safety features.
CenterVue designs and manufactures high-technological diagnostic systems for the early detection and the management of sight-threatening pathologies, such as Diabetic Retinopathy, Macular Degeneration and Glaucoma.
Our products portfolio includes: Retinal imaging systems, Fundus Automated Perimetry and Microperimetry devices.
CenterVue goal is to offer user-friendly and highly automated products that allow Eye Practitioners to preserve patients’ sight and quality of vision, in particular by detecting preventable diseases.
D.O.R.C. enhances global eye surgery and maximizes surgeon control by offering innovative quality approaches for eye disorders. Our product portfolio includes EVA UPGRADED phaco-vitrectomy system featuring the unique VTi pump (offering both FLOW and VACUUM fluidics) and TDC (two-dimensional cutting) vitrectome with cuts speeds of up to 16,000 CPM, an extensive range of anterior and posterior instruments including 27G ULTRA for no compromise small gauge surgery, as well as a wide range of highly purified anterior and posterior surgical liquids and tamponades. Inspired by you – created by D.O.R.C.
ESPION and CELERIS Electrophysiology systems from DIAGNOSYS for ERG, EOG, VEP, PERG, mfERG, Visual Acuity, Pupillometry and psychophysical testing including Full-Field Scotopic Threshold (FST) and DARK adaptometry provides innovative, high-quality functional examination and monitoring of disease & treatment progression in clinics, research, operating rooms, paediatrics, private practices and clinical trials.
As the world leader in modern visual electrophysiology, Diopsys, Inc. (http://diopsys.com/) has done more than any other company to advance the use of electroretinography (ERG) and visual evoked potential (VEP) in the eye care practice. Diopsys offers a full suite of visual electrophysiology modules, including PERG, ffERG, mfERG and VEP. Diopsys® ERG and VEP vision tests can be performed on the Diopsys® NOVA™ (cart), Diopsys® ARGOS™ (tabletop) or Retina Plus™ (carry case) system. The company’s unique, patented technology helps eye care professionals detect dysfunction early, track disease progression, and tailor treatment using objective results of visual function.
Ellex is committed to helping ophthalmic surgeons across the world diagnose, manage and treat a wide range of visual problems and eye diseases. To that end, we provide a comprehensive range of laser and ultrasound products for the diagnosis and treatment of cataract, glaucoma and retinal conditions. With our 2RT® Retinal Rejuvenation Therapy, we’re expanding our focus on the development of restorative, rejuvenative treatment options that work holistically with the body’s natural healing ability.
EURETINA is a non-profit organization also known as the European Society of Retina Specialists. The aims of EURETINA are:
• To establish personal contacts and to promote the exchange of knowledge between vitreoretinal and macula specialists in Europe.
• To stimulate and encourage vitreoretinal and macula research in Europe.
• To promote the diffusion of specific knowledge to general ophthalmologists in Europe.
• To keep contact with similar groups in other continents.
These aims are realized through the organization of annual scientific congresses, which offer members of the Society a forum for the exchange of ideas.
Eyenuk Inc., is a global artificial intelligence (AI) medical technology and services company and the leader in real-world AI Eye Screening™ for autonomous disease detection and AI Predictive Biomarkers™ for risk assessment and disease surveillance.
Eyenuk is on a mission to screen every eye in the world to ensure timely diagnosis of life- and vision-threatening diseases, including diabetic retinopathy, glaucoma, age-related macular degeneration, stroke risk, cardiovascular risk, and Alzheimer’s disease.
Retina : Invitria®, Laser Probes, Laser Illuminations Probes and Fiber Optic Probess, Vitreoretinal Instruments and Accessories, Trocars, Silicone oils, PFCL,Self Retaining Silicone Oil Cannulas, Scleral Buckles in Silicone, ePTFE Scleral Buckles, Backflush Handles & Cannulas, Vitrectomy Lenses, Three Mirror Lens, Vitrectomy Kit.
The Fight Retinal Blindness! project collects real-world data on treatments for retinal diseases: neovascular age-related macular degeneration (nAMD), choroidal neovascularisation other than nAMD, diabetic retinopathy and retinal vein occlusion. Data on over 20,000 eyes have been collected since 2007, thanks to nearly 500 doctors from over 300 practices who have joined the project. This has helped generate more than 30 research publications, coordinated by Professor Mark Gillies and a team of researchers at the University of Sydney. The project is run by the Save Sight Registries, which also collects data on keratoconus, glaucoma and ocular melanoma.
The Geuder Group represents innovation and research. Modern procedures cannot be performed without precise instruments, innovative systems, highly effective and well tolerated vitreoretinal fluids and vitreous substitutes. By providing such products, the Geuder Group aims to contribute to the success and ongoing development of the procedures in anterior and posterior eye segment surgeries.
Heidelberg Engineering continuously optimizes imaging and healthcare IT technologies to provide ophthalmic diagnostic solutions that empower clinicians to improve patient care. From its inception in 1990, the company has collaborated with scientists, clinicians and industry to develop innovative products that deliver clinically relevant benefits.
Uncompromising quality and education play a large part in fostering the diagnostic confidence that has become synonymous with the global brand.
The growing product portfolio combines these core technologies: confocal microscopy, scanning lasers and optics, optical coherence tomography (OCT), real-time image processing and analytics, multimodal image management solutions (PACS), electronic medical records (EMR), data mining.
In 1946 our founder, Helmut A. Heine started HEINE Optotechnik with one goal in mind; to build the highest quality diagnostic instruments available in the world. It was his belief that the highest quality instruments will always best support the health care professional in making the earliest and most accurate diagnosis. For over 70 years, our customers have been able to rely on this promise, and on their HEINE instruments for precise diagnostic performance, unique functionality and long lasting durability.
Today, as a global leader in primary diagnostic instruments with over 500 employees we remain committed to our founding principles.
French pharmaceutical laboratories founded in 2003.
Horus Pharma develops, patents and markets products in the ophtalmological and dermatological fields.
Icare Finland is the original developer of the rebound technique for
tonometry. The clinical performance and ease-of-use of our devices have
allowed Icare Finland to quickly become the global leader in handheld
tonometry. The Icare® product line offers a range of tonometry devices for accurate,
consistent and reproducible measurement of intraocular pressure in
virtually any circumstances. All Icare® devices are manufactured in Finland
under an ISO 13485-certified quality system.
Imagine Eyes is a leading pioneer in ophthalmic imaging. Its rtx1 camera enables examining patients’ retinas with an unprecedented level of detail: the cellular level. Thanks to adaptive optics technology, the rtx1 images individual cells, blood vessel walls and microscopic lesions in the retina with the highest resolution on the market. In addition, user-friendly software is available for driving quick examinations, tracking microscopic changes over time, and analyzing cellular and microvascular biomarkers. Imagine Eyes’ products are used worldwide in clinical research, including multicentric and therapeutic studies.
INCYTO CO., LTD. (Microneedles 38g~50g)
IRIDEX is a worldwide provider of laser-based medical systems, delivery devices, and consumable instrumentation for the treatment of glaucoma and retinal diseases. IRIDEX products, including the Cyclo G6 glaucoma laser, IQ 577 laser, IQ 532 laser, and TxCell scanning delivery system, are sold in the United States and Germany through direct sales, and in over 100 countries through a network of 70 distributors. More at iridex.com.
JP Medical publishes into the undergraduate, postgraduate and specialist markets. As the UK-based, wholly owned subsidiary of Jaypee Brothers Medical Publishers (P) Ltd, South Asia’s largest and fastest growing medical publisher, JP Medical distributes books, journals and online services in Europe, North America, the Middle East and Africa, and also publishes new titles from authors in these regions.
Karger Publishers is a worldwide publisher of scientific and medical content based in Basel, Switzerland. Connecting and advancing health sciences since 1890, Karger has been continuously evolving, keeping pace with the current developments and shifts in research and publishing. The publishing house is dedicated to serving the information needs of the scientific community, clinicians and patients with publications of high-quality content and services in health sciences.
Visit our booth and browse through the latest publications in Ophthalmology!
As goldsmiths and jewelry designers we value the individual and emotional aspect of the Retina. Therefore we put it into the center of our RetinaJewelry Collection. Have the retina of your beloved ones eternalized on a ring, pendant, earrings or cuff links. Like a secret language, only you are able to decode the origin of this beautiful pattern. Every piece of our handmade RetinaJewelry can exist only one single time in this world and therefore is a true declaration of love, not only unique like many other pieces of jewelry, but in direct personal relation with the one(s) you love.
LumiThera is committed to creating a brighter horizon for patients by developing treatment solutions utilizing Photobiomodulation to improve visual function, stop or slow the progression of debilitating eye diseases and prevent vision loss and blindness. LumiThera’s first product, the Valeda Light Delivery System, is the first approved treatment for Dry Age-Related Macular Degeneration using Photobiomodulation. Valeda improves visual acuity, improves contrast sensitivity, reduces central drusen volume, and is designed for ease of use in the clinician’s office. The Valeda Light Delivery System is in clinical trials and not approved for use in the United States. Visit www.lumithera.com to learn more.
Fueled by their mission to eliminate blindness caused by AMD, MacuLogix® provides eye care professionals with the instrument and education needed to effectively diagnose and manage patients with AMD.
Based on the science of dark adaptation, MacuLogix’s AdaptDx® provides a clear, objective measurement of retinal function that is 90% sensitive and 90% specific to the presence of AMD. Using a single number, the Rod Intercept™ (RI), AMD can be detected early – before drusen are visible – when a course of action may help delay or prevent blindness caused by AMD.
Media MICE is not your average ophthalmic media company. This Singapore-based medical publishing and marketing company produces content that is well-researched and well-written, in a style that is decidedly different in the ophthalmic world. Our magazine brands, PIE (Posterior Segment – Innovation – Enlightenment) and CAKE (Cataract – Anterior Segment – Kudos – Enlightenment), reveal this difference. We specialize in peer-reviewed manuscripts, medical writing and publishing. We do advertising, sponsored articles, global symposium coverage, e-blasts, product launch support, photoshoots, videos, congress show-dailies, custom newsletters, social media marketing, interactive content including creative booths/events, and other medical editorial and marketing products.
Our unique cannula products enable you to tackle a wide variety of retina cases using 23, 25, and 27 gauge systems. Come by to see our wide range of specialty cannulas, backflush instruments, silicone oil injection/removal products, DualBore SideFlō® Cannulas, an extensive line of Subretinal cannulas and other great new tools to help you achieve your surgical goals.
NIDEK provides a wide range of equipment for refraction, diagnosis, and treatment of vision disorders since 1971. At EURETINA, NIDEK is pleased to introduce our innovative products such as Multimodal Imaging Platform OCT/SLO Combo, OCT with OCT-Angiography, and Microperimeter. We cordially invite you to visit our booth at No.212 in Hall Maillot on level 2 and try out these unique devices for yourself. Also, we will have lunch symposium on 6th September. For details, please visit our web site, https://www.nidek-intl.com/news-event/event/entry-3488.html
Novartis is reimagining medicine to improve and extend people’s lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world’s top companies investing in research and development. Novartis products reach more than 750 million people globally and we are finding innovative ways to expand access to our latest treatments. About 105 thousand people of more than 140 nationalities work at Novartis around the world. Find out more at www.novartis.com.
OCULUS, the inventor of the SDI®/BIOM® system – the first non-contact wide angle viewing system for vitreoretinal surgery – set up a special department “OCULUS Surgical” to improve care of its exclusive circle of customers – ophthalmic surgeons. Ongoing improvement of existing products, trainings and distribution constitute the main tasks of this team of specialists.
The product range of the successful SDI®/BIOM® system is constantly expanding: in 2013 the new BIOM® ready was introduced, the world’s first disposable wide angle viewing system. Disposable OCULUS-quality lenses, so-called BIOM® Optic Sets, round out the assortment of disposable products.
„OD-OS is the global leader in the development and commercialization of navigated laser photocoagulators for Ophthalmology. OD-OS’ compact Navilas® Laser System 577s enables physicians to digitally pre-plan the entire laser therapy on fundus images as well as external diagnostic images and precisely execute this therapy plan under computer guidance. Unlike any other retina laser, Navilas offers focal treatments without a contact lens and infrared illumination for unsurpassed patient comfort. A large field of view and assisted pattern positioning greatly improve speed in panretinal and focal treatments.”
OERTLI® – MAKING THE DIFFERENCE IN EYE SURGERY.
With its excellent surgical devices and instruments that make surgical interventions safer, easier and more efficient. With lasting innovations and new technology that have long-term impact on cataract, glaucoma and vitreoretinal surgeries. With superb service and real added value for surgeons and OR personnel. And, in its consistent pursuit to accomplish the very best for customers, users and patients. The new ViPer™ Scleral Indentor is their latest innovation. It combines indenting and peripheral illumination making retinal surgery even safer, easier and more efficient.
OphtAI, the joint-venture between Adcis and Evolucare, dedicated to ophthalmology, is set to revolutionize eye diseases screening and diagnosis with its state of the art Artificial Intelligence based solution. With unmatched performances and highly flexible cloud tele-ophthalmology platform it stands unrivaled on the market and covers all specialty’s needs, from liberal practices to clinics and mobile operations. OphtAI’s solution results from years of collaborative research and intends to improve care for billions of people at risk of blindness worldwide. Today OphtAI covers diabetic retinopathy, the next release (due end 2019) will cover Glaucoma and AMD as well.
OPHTEC was founded in 1983 by ophthalmologist prof. Jan Worst (1925 – 2015) and his wife Mrs. Anneke Worst-van Dam. His inventions such as the Artisan lens have changed ophthalmology forever and today it is the company’s Vision to design, produce and market clinically innovative ophthalmic products, with a focus on perfection. During Euretina OPHTEC will present the versatility of the Artisan aphakia used in both posterior and anterior chamber of the eye with the possibility to help vitreoretinal surgeons during the most complicated aphakic cases. The Artisan can potentially help solving problems related to zonulophaty and zonules problems.
Optopol Technology, the manufacturer of the first Spectral Domain OCT in the world, is a Polish producer of original ophthalmic equipment for professionals. We have been on the market for almost 30 years.
So far this year we have launched the groundbreaking REVO FC which combines a Fundus Camera with a complete OCT functionality, including OCT Angiongraphy, Biometry OCT and Topography OCT. And at the coming conference in Paris we will be showing the REVO NX 130 featuring our iTracking technology which compensates involuntary eye movements and blinks. We will be delighted to see you in Paris.
Optos devices produce ultra-widefield optomap® images of approximately 82% or 200° of the retina, something no other device is capable of doing in a single capture. An optomap image provides a bigger picture and more clinical information which facilitates the early detection, management and effective treatment of disorders and diseases evidenced in the retina. Optos is committed to utilising the latest technology to manufacture new products and software that support optomap as a standard of care therefore helping eyecare professionals around the world save sight and lives.
Optovue, Inc. is a privately held medical device company founded in 2003. Headquartered in Fremont, Calif., the company is dedicated to the advancement and commercialization of high-speed OCT and OCTA technology used to facilitate the diagnosis and management of eye diseases, many of which may lead to permanent blindness. Optovue is the first company to develop and commercialize the pioneering OCTA technology. To date, there are over 400 peer-reviewed publications detailing the AngioVue® OCTA imaging technology and clinical applications. The company has installed over 12,000 products worldwide. For more information, visit www.optovue.com.
Oxurion (Euronext Brussels: OXUR) is a biopharmaceutical company currently developing a competitive pipeline of disease-modifying drug candidates for diabetic eye disease, a leading cause of blindness in people of working age worldwide.
Oxurion owns the global rights to JETREA® (ocriplasmin), the only pharmacological vitreolysis drug approved for the treatment of symptomatic vitreomacular adhesion (in the US) and vitreomacular traction (outside the US).
More information is available at www.oxurion.com.
Phakos, French company produce single use retinal device
Preceyes BV is a medical robotics company with a CE-marked product for treatment of patients requiring vitreoretinal surgery. We fight visual impairment and blindness by developing novel, high-precision drug delivery treatments and by improving the precision of surgical treatments. Our long-term vision is to transition eye surgery to its next evolution where robotics enables novel therapies, standardizes and improves surgical performance, and provides significant cost-saving by shifting the surgical suite to an office-based setting. www.preceyes.nl
Created in 1993, Quantel Medical is a fully owned subsidiary of the Lumibird Group. Its core activities are the development, manufacturing and commercialization of innovative solutions in medical lasers and ultrasound technologies.
Present in over 110 countries either direct or through distributors, Quantel Medical has become a world leader in the ophthalmic field. We address the needs of ophthalmologists to diagnose and treat patients affected by the four major causes of blindness: cataract, glaucoma, diabetic retinopathy and macular degeneration.
Since 2018, Quantel Medical also offers a complete range of diagnosis and treatment of the dry eye syndrome
RetinAI™ develops software solutions to accelerate and support clinical and pharmaceutical research workflows, making health institutions smarter and more efficient. The company builds tools to collect and analyse health data from the eyes, empowering communities of healthcare professionals and patients with data analysis supported by computer vision, signal processing & AI.
The flagship product, RetinAI Discovery®, is a tool does not require additional hardware, works via the web browser inside the hospital and enables analysis and transfer of medical data from the eyes, connecting devices, data sources & decisions in a seamless and easy manner.
Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and neuroscience. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Roche’s personalised healthcare strategy aims at providing medicines and diagnostics that enable tangible improvements in the health, quality of life and survival of patients.
For more information, please visit roche.com
RUMEX International Corporation is one of the leading manufacturers of surgical instruments for handheld surgery with many offices and representatives all over the world.
Our Major specialization lies within reusable instruments for surgical ophthalmology and cardiovascular and thoracic surgery.
Italian multinational developer and leading manufacturer (FDA-approved operations) of innovative products mainly based on hyaluronic acid (700+ patents), has entered the ophthalmic market segment, with a range of pharmaceuticals, medical devices, and dietary supplements for the prevention and treatment of general and specific eye disorders and conditions, as well as novel technologies for the treatment of keratoconus.
At SUOER we focus on R&D of high-frequency Ultrasound and Optical Technology equipment for opticians and optometrist.We have established a technical cooperation relationship with University of Southern California. We have a strong R&D team, and excellent development technology. Our main products include: Ophthalmic Ultrasound Bio-microscopy, Ophthalmic A/B Scan, A/P Scan, Fundus Camera, Vision Screener, Optical Biometer, Corneal Topographer and more!
Shenzhen Thondar Technology Co., Ltd is a state-level high-tech enterprise, focusing on the development of cutting-edge ophthalmic diagnostic and treatment techniques, to help doctors and practitioners achieve better medical services, and to contribute to the development of global health undertakings. Thondar is the pioneer and innovator in China to introduce multi-spectral imaging technology into fundus diagnosis, and will continuously launch inspection and diagnostic equipment based on this technology. With the vision ahead, Thondar has initiated international business, with a goal of building an internationally renowned medical equipment brand.
Topcon Eye Care company provides ophthalmic instruments for examination, diagnosis, treatment as well as optometric instruments for refraction and eye-glass lens processing.
Topcon’s new strategic division, Topcon Healthcare Solutions, creates innovative software solutions aimed to solve existing data management and communication challenges experienced by eyecare specialists. These next-generation software applications allow you to connect all of your diagnostic instruments, regardless of manufacturer, in one secure, web-based platform, while supporting both Artificial Intelligence integrations and telemedicine.
Topcon Healthcare Solutions’ vendor-neutral software enables the collection and visualisation of a wide range of imaging and clinical data while providing clinical analysis capabilities. Our innovative products give clinicians access to patient exam data captured from OCTs, Visual Fields, Fundus Cameras, and other Topcon and third-party devices. With a focus on vendor-neutral device connectivity, our software gives clinicians access to DICOM and non-DICOM information stored in a central, cloud-based environment. Additionally, supporting AI integrations our software assists in early detection of sight-threatening eye diseases.
Vesber Biotechnology Co., Ltd. has worked intensively with leading top international ophthalmic centers and surgeons. Engaged in the research, development, manufacture and sales of high-tech ophthalmic medical products. Foldable Capsular Vitreous Body is used to treat severe retinal detachment, silicone oil dependent eyes and severe ocular trauma.
Vitreocare is an Alfa Instruments owned-brand, born in 2017, engaged in the manufacturing and marketing of lutein-based intra-ocular dyes for vitreoretinal surgeries.
Vitreq is an innovative company specialized in producing high quality instruments for the international ophthalmic society.
Vitreq creates instruments for the ophthalmic society with a special focus on
vitreoretinal surgery. Our products are perfectly matched to your needs.
Fluid design that is achieved through working hand-in-hand with leading,
innovative surgeons from all over the world.